Randomised non-comparative trial

A randomised non-comparative trial, RNCT (or also non-comparative randomised trial[1]), is a type of clinical trial where participants are randomised to different conditions (arms), but where the primary analysis involves comparing each arm separately to a historical control, predefined benchmark or something else, with no formal comparison between the two arms.[2]

The study design appears to have arisen in oncology, where single-arm studies are not unusual. It promises reduced sample size requirements.[3] An RNCT acts like multiple single-arm designs run concurrently.[2] A review found RNCTs dating back to 2002, and having been used in high-profile oncology studies and also beyond oncology.[3]

The design has been criticised by statisticians. It is unclear what benefit randomisation adds compared to running separate single-arm studies.[3] Pavlos Msaouel described the use of the word "randomisation" as merely being "talismanic" in a 2025 article, it leading readers to think the study has the benefits of a randomised controlled trial (RCT).[2] While the point of an RNCT is not to have a comparison between arms, about half of reported RNCTs still reported some sort of comparison.[3]

References

  1. ^ Sundar, Shyam; Pandey, Krishna; Mondal, Dinesh; Madhukar, Major; Kamal Topno, Roshan; Kumar, Ashish; Kumar, Vinod; Kumar Verma, Deepak; Chakravarty, Jaya; Chaubey, Rahul; Kumari, Poonam; Rashid, Md. Utba; Maruf, Shomik; Ghosh, Prakash; Raja, Sheeraz; Rode, Joelle; den Boer, Margriet; Das, Pradeep; Alvar, Jorge; Rijal, Suman; Alves, Fabiana (2024-06-20). "A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh". PLOS Neglected Tropical Diseases. 18 (6) e0012242. doi:10.1371/journal.pntd.0012242. ISSN 1935-2735. PMC 11189210. PMID 38900786.
  2. ^ a b c Msaouel, Pavlos (2025-03-28). "The curious rise of randomised non-comparative trials". Significance. 22 (3): 40–44. doi:10.1093/jrssig/qmaf029. ISSN 1740-9705. Retrieved 2025-04-17.
  3. ^ a b c d Sherry, Alexander D.; Msaouel, Pavlos; Ludmir, Ethan B. (2024). "A meta-epidemiological analysis of post-hoc comparisons and primary endpoint interpretability among randomized noncomparative trials in clinical medicine". Journal of Clinical Epidemiology. 175 111540. doi:10.1016/j.jclinepi.2024.111540. Retrieved 2025-04-17.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.